Phase 1/2 study of cirmtuzumab and ibrutinib in mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL).

被引：16

作者：

Lee, Hun Ju

Choi, Michael Y.

Siddiqi, Tanya

Barrientos, Jacqueline Claudia

Wierda, William G.

Isufi, Iris

Tuscano, Joseph M.

Lamanna, Nicole

Subbiah, Suki

Koff, Jean Louise

Leslie, Lori Ann

Goldenberg, Alec

Chung, Gina G.

Breitmeyer, James Bradley

Hsu, Frank J.

Wang, Michael

Jamieson, Catriona

Kipps, Thomas J.

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA

[2] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA

[3] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA

[4] Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY USA

[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[6] Yale Univ, Sch Med, Hematol, New Haven, CT USA

[7] Univ Calif Davis, Davis, CA 95616 USA

[8] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY USA

[9] LSU Hlth Sci Ctr, New Orleans, LA USA

[10] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[11] John Theurer Canc Ctr, Lymphoma Res Div, Hackensack, NJ USA

[12] Manhattan Hem Onc Associates, New York, NY USA

[13] Christ Hosp, Lindner Ctr Res & Educ, Cincinnati, OH 45219 USA

[14] Oncternal Therapeut Inc, San Diego, CA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.7556

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

7556

引用

页数：3

共 50 条

[31] Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties
Dreger, Peter
Michallet, Mauricette
Bosman, Paul
Dietrich, Sascha
Sobh, Mohamad
Boumendil, Ariane
Nagler, Arnon
Scheid, Christof
Cornelissen, Jan
Niederwieser, Dietger
Mueller, Lutz
Vandenberghe, Elizabeth
Scortechini, Ilaria
Schoemans, Helene
Andersen, Niels S.
Finke, Juergen
Russo, Domenico
Ljungman, Per
Passweg, Jakob
van Gelder, Michel
Durakovic, Nadira
Labussiere-Wallet, Helene
Berg, Tobias
Wulf, Gerald
Bethge, Wolfgang
Bunjes, Donald
Stilgenbauer, Stefan
Canepari, Maria Elisa
Schaap, Michel
Fox, Christopher P.
Kroeger, Nicolaus
Montoto, Silvia
Schetelig, Johannes
BONE MARROW TRANSPLANTATION, 2019, 54 (01) : 44 - 52
[32] Phase Ib Study of Ianalumab (VAY736) and Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL) on Ibrutinib Therapy
Rogers, Kerry A.
Flinn, Ian W.
McGarry, Carolyn
Gou, Liangke Connie
Hassounah, Nadia
Woo, Janghee
Byrd, John C.
BLOOD, 2020, 136
[33] Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties
Peter Dreger
Mauricette Michallet
Paul Bosman
Sascha Dietrich
Mohamad Sobh
Ariane Boumendil
Arnon Nagler
Christof Scheid
Jan Cornelissen
Dietger Niederwieser
Lutz Müller
Elizabeth Vandenberghe
Ilaria Scortechini
Helene Schoemans
Niels S. Andersen
Jürgen Finke
Domenico Russo
Per Ljungman
Jakob Passweg
Michel van Gelder
Nadira Durakovic
Helene Labussiere-Wallet
Tobias Berg
Gerald Wulf
Wolfgang Bethge
Donald Bunjes
Stefan Stilgenbauer
Maria Elisa Canepari
Michel Schaap
Christopher P. Fox
Nicolaus Kröger
Silvia Montoto
Johannes Schetelig
Bone Marrow Transplantation, 2019, 54 : 44 - 52
[34] Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study
Hoeller, Sylvia
Zhou, Yi
Kanagal-Shamanna, Rashmi
Xu-Monette, Zijun Y.
Hoehn, Daniela
Bihl, Michel
Swerdlow, Steven H.
Rosenwald, Andreas
Ott, German
Said, Jonathan
Dunphy, Cherie H.
Bueso-Ramos, Carlos E.
Lin, Pei
Wang, Michael
Miranda, Roberto N.
Tzankov, Alexander
Medeiros, L. Jeffrey
Young, Ken H.
HUMAN PATHOLOGY, 2013, 44 (01) : 110 - 121
[35] Is Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) a Lymphoma of Mantle Zone B-Cells?
Tandon, B.
Swerdlow, S. H.
Hasserjian, R. P.
Gibson, S. E.
LABORATORY INVESTIGATION, 2013, 93 : 364A - 364A
[36] Is Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) a Lymphoma of Mantle Zone B-Cells?
Tandon, B.
Swerdlow, S. H.
Hasserjian, R. P.
Gibson, S. E.
MODERN PATHOLOGY, 2013, 26 : 364A - 364A
[37] TRANSCEND CLL 004: Phase 1 Cohort of Lisocabtagene Maraleucel in Combination With Ibrutinib for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
不详
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (01) : 18 - 19
[38] A PHASE 2 STUDY OF THE BTK INHIBITOR IBRUTINIB IN GENETIC RISK-STRATIFIED RELAPSED AND REFRACTORY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL)
Maddocks, K.
Flynn, J. M.
Andritsos, L. A.
Awan, F.
Woyach, J. A.
Grever, M. R.
Stefanos, M.
Lynch, J.
Johnson, A. J.
Byrd, J. C.
Jones, J. A.
HAEMATOLOGICA, 2014, 99 : 522 - 522
[39] Ibrutinib in patients with autoimmune cytopenias and previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) from the phase 3 RESONATETM study
Montillo, Marco
O'Brien, Susan
Tedeschi, Alessandra
Byrd, John
Dearden, Claire
Gill, Devinder
Brown, Jennifer
Barrientos, Jacqueline
Mulligan, Stephen
Furman, Richard
Cymbalista, Florence
Plascencia, Clara
Chang, Stephen
Hsu, Emily
James, Danelle
Hillmen, Peter
LEUKEMIA & LYMPHOMA, 2015, 56 : 150 - 151
[40] Synergistic Cytotoxicity of Ibrutinib and the BCL2 Antagonist, ABT-199(GDC-0199) in Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL): Molecular Analysis Reveals Mechanisms of Target Interactions
Portell, Craig A.
Axelrod, Mark
Brett, L. Kyle
Gordon, Vicki L.
Capaldo, Brian
Xing, Jeffrey C.
Bekiranov, Stephan
Williams, Michael E.
Weber, Michael J.
BLOOD, 2014, 124 (21)

← 1 2 3 4 5 →